Clinical Trial Update: Definitive Therapy for Oligometastatic Solid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for definitive therapy in oligometastatic solid malignancies, including Stage IV or recurrent carcinoma or sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Sarcoma

Snippet

Sponsor: Rocky Mountain Cancer Centers | Conditions: Stage IV or Recurrent Carcinoma or Sarcoma | Phase 2 | Status: UNKNOWN